Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical implications of molecular analysis in diffuse glioma stratification.

Brain tumor pathology - 1 Jul 2021

Mizoguchi Masahiro, Hata Nobuhiro, Kuga Daisuke, Hatae Ryusuke, Akagi Yojiro, Sangatsuda Yuhei, Fujioka Yutaka, Takigawa Kosuke, Funakoshi Yusuke, Suzuki Satoshi O, Iwaki Toru

Abstract excerpt

The revised 4th edition of the 2016 World Health Organization Classification of Tumors of the Central Nervous System (2016 CNS WHO) has introduced the integrated diagnostic classification that combines molecular and histological diagnoses for diffuse gliomas. In this study, we evaluated the molecular alterations for consecutive 300 diffuse glioma cases (grade 2, 56; grade 3, 62; grade 4, 182) based on this...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Astrocytoma
Share to Chromosomes, Human, Pair 1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chromosomes, Human, Pair 10

Share to Chromosomes, Human, Pair 19

Share to Neoplasm Grading

Share to Oligodendroglioma

Share to Telomerase

Share to World Health Organization

Source

Identifiers

PMID: 34268651
DOI: 10.1007/s10014-021-00409-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical implications of molecular analysis in diffuse glioma stratification.PMID 34268651Read ↗

A clinical perspective on the 2016 WHO brain tumor classification and routine molecular diagnosticsSemantic proximity Read ↗

Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylationSemantic proximity Read ↗

Tailored therapy in diffuse gliomas: using molecular classifiers to optimize clinical management.Semantic proximity Read ↗

Prognostic relevance of genetic alterations in diffuse lower-grade gliomas.Semantic proximity Read ↗

Clinical management and survival outcomes of patients with different molecular subtypes of diffuse gliomas in China (2011-2017): a multicenter retrospective study from CGGA.Semantic proximity Read ↗

Clinical impact of revisions to the WHO classification of diffuse gliomas and associated future problems.Semantic proximity Read ↗

New molecular prognostic factors of adult diffuse lower-grade gliomas in post-2016 molecular era: a retrospective analysis from single center.Semantic proximity Read ↗

DNA methylation signatures for 2016 WHO classification subtypes of diffuse gliomasSemantic proximity Read ↗

Diffuse Gliomas for Nonneuropathologists: The New Integrated Molecular Diagnostics.Semantic proximity Read ↗

IDH-wildtype lower-grade diffuse gliomas: the importance of histological grade and molecular assessment for prognostic stratification.Semantic proximity Read ↗

Molecular Genetics of GliomasSemantic proximity Read ↗

[Clinicopathological and molecular genetic characteristics of adult IDH wild-type diffuse gliomas].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.